Therapeutic Drug Monitoring

Therapeutic drug monitoring (TDM), a fundamental component of clinical pharmacokinetics, enables the personalization of medication therapy to maximize effectiveness and reduce side effects. The ideas, applications, and clinical practice implications of TDM are thoroughly examined in this chapter. First, the theory underpinning TDM is explained, stressing how crucial it is to keep drug concentrations within therapeutic windows to accomplish intended therapeutic effects without running the risk of toxicity. In the context of TDM, important pharmacokinetic characteristics including clearance, volume of distribution, and half-life are covered, emphasizing their function in directing dosage modifications. Additionally, the benefits and drawbacks of several analytical methods used in TDM, such as mass spectrometry, chromatography, and immunoassays, in terms of precisely and consistently measuring drug concentrations, are discussed. To maintain clinical relevance and accuracy, the significance of appropriate specimen collection, handling, and interpretation of TDM data is emphasized. Further, TDM’s clinical uses for a variety of therapeutics—such as immunosuppressants, antiepileptics, antibiotics, and antineoplastics—are investigated. Examples from real-world clinical settings show how TDM helps with dosage regimen optimization, adherence monitoring, and therapeutic decision-making guidance. To sum up, TDM is a useful technique in clinical pharmacokinetics, providing tailored dosage regimens to optimize therapeutic effectiveness and reduce side effects. To further enhance patient outcomes and healthcare delivery, future research should concentrate on improving TDM’s accessibility, standardization, and incorporation into regular clinical practice.